Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspases.

Javorina Milosevic1, Sandra Hoffarth, Claudia Huber

  • 1Gene Therapy Laboratory, Johannes Gutenberg University, 55101 Mainz, Germany.

Oncogene
|October 10, 2003
PubMed
Summary

DNA damage triggers apoptosis via mitochondrial pathways. This study reveals that proapoptotic Bcl-2 family proteins, not decreased antiapoptotic Bcl-2, initiate the release of cytochrome c, activating caspases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erdafitinib in Patients With Advanced Solid Tumors With <i>FGFR</i> Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.

JCO precision oncology·2026
Same author

Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors.

Journal of hematology & oncology·2026
Same author

Phase 3 Study of Niraparib-Plus-Pembrolizumab as Maintenance Therapy for Advanced/Metastatic Non-Small Cell Lung Cancer (ZEAL-1L).

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Large language models enable prognostic stratification of cancer patients using real-world clinical notes.

PLOS digital health·2026
Same author

Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma.

European journal of cancer (Oxford, England : 1990)·2026
Same author

SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [<sup>68</sup>Ga]Ga-DOTATOC and [<sup>68</sup>Ga]Ga-SSO120 with [<sup>18</sup>F]FDG PET.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Area of Science:

  • Cellular biology
  • Molecular biology
  • Biochemistry

Background:

  • Apoptosis is crucial for development and disease.
  • DNA damage and radiation induce apoptosis through intrinsic and extrinsic pathways.
  • The mitochondrial pathway involves caspase activation and Bcl-2 family proteins.

Purpose of the Study:

  • To investigate the role of Bcl-2 family proteins in DNA damage-induced apoptosis.
  • To determine whether downregulation of antiapoptotic Bcl-2 or activation of proapoptotic proteins initiates mitochondrial apoptosis.
  • To elucidate the mechanism of cytochrome c release in response to DNA damage.

Main Methods:

  • Utilized murine embryonic fibroblasts (MEF) proficient and deficient in Apaf1.
  • Assessed DNA damage response using Western blotting for Bcl-2 and Noxa.

Related Experiment Videos

  • Measured Bax activation, cytochrome c release, and mitochondrial membrane potential (Deltapsim).
  • Investigated the effect of caspase inhibition on Bcl-2 levels.

    • Main Results:

    • DNA damage induced proapoptotic Noxa and Bax activation in both wt and apaf1(-/-) MEF.
    • Cytochrome c release and mitochondrial depolarization occurred irrespective of Apaf1 status.
    • Bcl-2 downregulation was observed only in wt MEF and was prevented by caspase inhibition.
    • Apaf1(-/-) MEF showed defective effector caspase activation and apoptosis despite mitochondrial events.

    Conclusions:

    • Activation of proapoptotic Bcl-2 family proteins, not Bcl-2 downregulation, is the primary signal for mitochondrial apoptogenic protein release.
    • Caspase activation downstream of cytochrome c release is essential for apoptosis following DNA damage.
    • Apaf1 is critical for effector caspase activation and subsequent apoptosis, but not for the initial mitochondrial permeabilization signal.